Prevention of heterotopic ossification after total hip replacement with NSAIDs

被引:63
|
作者
Fijn, R
Koorevaar, RT
Brouwers, JRBJ
机构
[1] Univ Groningen Inst Drug Explorat, Groningen Res Inst Pharm GRIP, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands
[3] W Fries Gasthuis, Dept Clin Pharm, Hoorn, Netherlands
[4] Univ Nijmegen Hosp, Dept Orthopaed, NL-6500 HB Nijmegen, Netherlands
[5] Leeuwarden & Tjongerschans Hosp, Dept Clin Pharmacol, Leeuwarden Med Ctr, Heerenveen, Netherlands
[6] Leeuwarden & Tjongerschans Hosp, Dept Hosp Pharm, Leeuwarden Med Ctr, Heerenveen, Netherlands
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 04期
关键词
COX-2; inhibitors; diclofenac; heterotopic ossification (HO); indomethacin; naproxen; non-steroidal; anti-inflammatory drugs (NSAIDs); rofecoxib;
D O I
10.1023/A:1024830213832
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: non steroidal anti-inflammatory drugs ( NSAIDs) and prophylactic radiotherapy can prevent ectopic bone formation around the hip after total hip arthroplasty. Methods: We retrieved from Medline, Embase and the Cochrane Register ( clinical) trials and other relevant literature on the prevention of heterotopic ossification (HO) from 1990-2002 for further review. Results: Review of these clinical trials shows that HO is effectively prevented by a postoperative NSAID treatment with indomethacin for at least seven days. The best evidence is available for indomethacin, although naproxen, diclofenac and ibuprofen are also well documented. Short term use of ibuprofen is not effective. If NSAIDs are contraindicated, preoperative or postoperative radiotherapy is a very effective therapeutic option to prevent HO. Discussion and conclusion: Because of the potential of serious gastrointestinal side effects of NSAIDs and their interaction with anticoagulant drugs, rofecoxib and other COX-2 specific NSAIDs may be a safer option for the treatment of HO. However, randomised controlled studies are needed to confirm the results of the rofecoxib study.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 50 条
  • [1] Prevention of heterotopic ossification after total hip replacement with NSAIDs
    R. Fijn
    R.Th. Koorevaar
    J.R.B.J. Brouwers
    Pharmacy World and Science, 2003, 25 : 138 - 145
  • [2] Preliminary study of rofecoxib (25 mg) in prevention of heterotopic ossification after total hip replacement
    F. Franchin
    F. Sanguineti
    G. Caione
    Journal of Orthopaedics and Traumatology, 2004, 5 (2) : 77 - 80
  • [3] Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty
    Romanò, CL
    Duci, D
    Romanò, D
    Mazza, M
    Meani, E
    JOURNAL OF ARTHROPLASTY, 2004, 19 (01) : 14 - 18
  • [4] The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement
    Pakos, E. E.
    Tsekeris, P. G.
    Paschos, N. K.
    Pitouli, E. J.
    Motsis, E. K.
    Xenakis, T. A.
    JOURNAL OF BUON, 2010, 15 (01): : 74 - 78
  • [5] Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty
    Robert Legenstein
    Peter Bösch
    Alfred Ungersböck
    Archives of Orthopaedic and Trauma Surgery, 2003, 123 : 91 - 94
  • [6] Combined Radiotherapy and Indomethacin for the Prevention of Heterotopic Ossification after Total Hip Arthroplasty
    Pakos, Emilios E.
    Stafilas, Kosmas S.
    Tsekeris, Pericles G.
    Politis, Aggelos N.
    Mitsionis, Gregory
    Xenakis, Theodore A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (08) : 500 - 505
  • [7] Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty
    Legenstein, R
    Bösch, P
    Ungersböck, A
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2003, 123 (2-3) : 91 - 94
  • [8] Rofecoxib inhibits heterotopic ossification after total hip arthroplasty
    van der Heide, Huub J. L.
    Koorevaar, Rinco C. T.
    Lemmens, J. Albert M.
    van Kampen, Albert
    Schreurs, B. Willem
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2007, 127 (07) : 557 - 561
  • [9] Rofecoxib inhibits heterotopic ossification after total hip arthroplasty
    Huub J. L. van der Heide
    Rinco C. T. Koorevaar
    J. Albert M. Lemmens
    Albert van Kampen
    B. Willem Schreurs
    Archives of Orthopaedic and Trauma Surgery, 2007, 127 : 557 - 561
  • [10] Heterotopic ossification following total hip replacement for acetabular fractures
    Chemaly, O.
    Hebert-Davies, J.
    Rouleau, D. M.
    Benoit, B.
    Laflamme, G. Y.
    BONE & JOINT JOURNAL, 2013, 95B (01) : 95 - 100